EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Targeting metabolic adaptive responses induced by glucose starvation inhibits cell proliferation and enhances cell death in osimertinib-resistant non-small cell lung cancer (NSCLC) cell lines

Kamal Eltayeb, Roberta Alfieri, Claudia Fumarola, Mara Bonelli, Maricla Galetti, Andrea Cavazzoni, Graziana Digiacomo, Francesca Galvani, Federica Vacondio, Alessio Lodola, Marco Mor, Roberta Minari und 3 weitere

Biochemical Pharmacology · 2024-10 · 228 · 116161

DOI: 10.1016/j.bcp.2024.116161 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biochemical Pharmacology, 2024-10. Verfasst von Kamal Eltayeb und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine and Surgery, University of Parma, 43126 Parma, Italy. Hauptthemen laut MEDLINE: Acrylamides, Carcinoma, Non-Small-Cell Lung, Cell Proliferation, Aniline Compounds. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Airc Italian Foundation for Cancer Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Osimertinib, a tyrosine kinase inhibitor targeting mutant EGFR, has received approval for initial treatment in patients with Non-Small Cell Lung Cancer (NSCLC). While effective in both first- and second-line treatments, patients eventually develop acquired resistance. Metabolic reprogramming represents a strategy through which cancer cells may resist and adapt to the selective pressure exerted by the drug. In the current study, we investigated the metabolic adaptations associated with osimertinib-resistance in NSCLC cells under low glucose culture conditions. We demonstrated that, unlike osimertinib-sensitive cells, osimertinib-resistant cells were able to survive under low glucose conditions by increasing the rate of glucose and glutamine uptake and by shifting towards mitochondrial metabolism. Inhibiting glucose/pyruvate contribution to mitochondrial respiration, glutamine deamination to glutamate, and oxidative phosphorylation decreased the proliferation and survival abilities of osimertinib-resistant cells to glucose starvation. Our findings underscore the remarkable adaptability of osimertinib-resistant NSCLC cells in a low glucose environment and highlight the pivotal role of mitochondrial metabolism in mediating this adaptation. Targeting the metabolic adaptive responses triggered by glucose shortage emerges as a promising strategy, effectively inhibiting cell proliferation and promoting cell death in osimertinib-resistant cells.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AcrylamidesCarcinoma, Non-Small-Cell LungCell ProliferationAniline CompoundsLung NeoplasmsDrug Resistance, NeoplasmGlucoseHumansCell Line, TumorAntineoplastic AgentsCell DeathMitochondriaIndolesPyrimidines

Stichwörter der Autor:innen

EGFRGlucoseMetabolismNSCLCOsimertinibResistance

Substanzen

AcrylamidesosimertinibAniline CompoundsGlucoseAntineoplastic AgentsIndolesPyrimidines

Autor:innen und Institutionen

  • Department of Medicine and Surgery, University of Parma, 43126 Parma, Italy.
  • Department of Medicine and Surgery, University of Parma, 43126 Parma, Italy. Electronic address: roberta.alfieri@unipr.it.
  • Department of Occupational and Environmental Medicine, Epidemiology and Hygiene, INAIL-Italian Workers' Compensation Authority, Monte Porzio Catone, 00078 Rome, Italy.
  • Department of Food and Drug, University of Parma, 43124 Parma, Italy.
  • Medical Oncology Unit, University Hospital of Parma, 43126 Parma, Italy.
  • Department of Medicine and Surgery, University of Parma, 43126 Parma, Italy; Medical Oncology Unit, University Hospital of Parma, 43126 Parma, Italy.

Förderung

  • Airc Italian Foundation for Cancer Research

Zitieren

APA

Eltayeb, K., Alfieri, R., Fumarola, C., Bonelli, M., Galetti, M., Cavazzoni, A., Digiacomo, G., Galvani, F., Vacondio, F., Lodola, A., Mor, M., Minari, R., Tiseo, M., La Monica, S., & Giorgio Petronini, P. (2024). Targeting metabolic adaptive responses induced by glucose starvation inhibits cell proliferation and enhances cell death in osimertinib-resistant non-small cell lung cancer (NSCLC) cell lines. Biochemical Pharmacology, 228, 116161. https://doi.org/10.1016/j.bcp.2024.116161

Vancouver

Eltayeb K, Alfieri R, Fumarola C, Bonelli M, Galetti M, Cavazzoni A, et al. Targeting metabolic adaptive responses induced by glucose starvation inhibits cell proliferation and enhances cell death in osimertinib-resistant non-small cell lung cancer (NSCLC) cell lines. Biochemical Pharmacology. 2024;228:116161. doi:10.1016/j.bcp.2024.116161

BibTeX
@article{Eltayeb2024,
  author = {Eltayeb, Kamal and Alfieri, Roberta and Fumarola, Claudia and Bonelli, Mara and Galetti, Maricla and Cavazzoni, Andrea and Digiacomo, Graziana and Galvani, Francesca and Vacondio, Federica and Lodola, Alessio and Mor, Marco and Minari, Roberta and Tiseo, Marcello and La Monica, Silvia and Giorgio Petronini, Pier},
  title = {Targeting metabolic adaptive responses induced by glucose starvation inhibits cell proliferation and enhances cell death in osimertinib-resistant non-small cell lung cancer (NSCLC) cell lines},
  journal = {Biochemical Pharmacology},
  year = {2024},
  volume = {228},
  pages = {116161},
  doi = {10.1016/j.bcp.2024.116161}
}
Kostenlos starten →